1214-P: Prepregnancy Use of Glucagon-Like Peptide 1 Receptor Agonists and Gestational Weight Gain in Type 2 DiabetesJacqueline Maya, CAMILLE E. POWE, SARAH HSU et al.|Diabetes|2024Cited by 7
1217-P: Insulin Sensitivity and Insulin Secretion Differentially Affect Birthweight and Postpartum GlucoseEmily A. Rosenberg, Arantxa Medina Baez, Kaitlyn James et al.|Diabetes|2024Cited by 0
1252-P: Glucagon-Like Peptide 1 Receptor Agonist Prescription prior to Pregnancy According to Health Insurance Type and Race/EthnicityCAROLINA I. BATLLE, Jacqueline Maya, Tanayott Thaweethai et al.|Diabetes|2025Cited by 0
1234-P: Glucagon-Like Peptide 1 Receptor Agonists Use prior to Pregnancy Is Not Associated with Abnormal BirthweightJacqueline Maya, CAMILLE E. POWE, Yaqun Fu et al.|Diabetes|2025Cited by 0